Kraig Biocraft Laboratories, Inc.
corporate_fare Company Profile
Kraig Biocraft Laboratories, Inc. (OTC:KBLB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 16 items for KBLB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-24, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 14 rated 8 or above. Recent SEC coverage for KBLB spans 10-Q, 424B3, 8-K.
Recent high-impact activity:
- Kraig Biocraft Boosts Spider Silk Output 30% in Rainy Season, Eyes More Land
- Kraig Biocraft Labs Achieves New Record: Delivers Nearly 2.5 Metric Tons of Recombinant Spider Silk
- Immortalized Silk Gland Cell Breakthrough Promises Enhanced Spider Silk Production for Kraig Biocraft Labs
- Zero Revenue, $1M Net Loss for Kraig Biocraft in Q1
- Kraig Biocraft Laboratories Reports Widening Losses, Zero Revenue, and Going Concern Warning Amid Ineffective Controls
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 5,100 shares in KBLB as of the September 15, 2026 settlement, a 91.4% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 35.5% of KBLB volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for KBLB, detected from its recent SEC filings · based on capital-structure filings through 2026-05-22.
Significant Share Overhang Created · No Direct Proceeds for Company
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →